Crowdonomics
WatchlistPortfolio
All companies

RedOak Instruments, LLC

Operating

Healthcare · Founded 2008

Visit website

Red Oak Instruments produces biomedical devices that allow quantitative measurements of fine motor skills and provides doctors and physicians with new ways to measure a patient’s functionality, aiding them in their diagnosis. Why Guess? Measure.

Post-money valuation ⓘ
$7.0M
As of Apr 2021 · from Reg CF Offering (2021) · pre-money + amount raised, not a traded price
Total raised
$47,080
Across 1 round since 2021
Latest share price
$2.00
Reg CF · Common Stock · Feb 2021 offering price

Financials

FY2018–FY2021 · from SEC filings · hover any figure for its source
$0
−$277K
2018
$0
−$243K
2019
$0
−$185K
2020
$0
−$49K
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018 reviewed
FY2019 reviewed
FY2020
FY2021
Income statement
Revenue
$0
$0
$0
$0
Cost of goods sold
$75,389
$0
$0
$0
Net income
-$276,797
-$243,003
-$184,698
-$48,716
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$126,565
$17,987
$1,882
$9,098
Accounts receivable
$0
$0
$0
$0
Total assets
$180,467
$70,738
$68,636
$75,852
Short-term debt
$4,983
$257
$0
$0
Long-term debt
$0
$0
$0
$0
Total liabilities
$4,983
$257
$0
$0
Other
Headcount
—
0
—
0

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$6.9M
pre-money
Reg CF · Common · Feb 2021

Blue bars are the pre-money valuation the company stated for a priced round.

Fundraising history

Reg CF · Common Stock · Feb 2021Closedvia Netcapital
Raised $47.1K / $1MPost-money $7M

Team

2 people
Richard Behlmann
Principal Executive Officer
William Paske
Principal Accounting Officer

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Possibly delinquent

Filed 1 of 6 annual reports (FY2020–FY2025)

Missing: 2020, 2022, 2023, 2024, 2025

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARMay 6, 20220001836234-22-000002
    EDGAR
  • Form C-UAug 6, 20210001669191-21-000782
    EDGAR
  • Form C/AMar 31, 20210001669191-21-000330
    EDGAR
  • Form CFeb 1, 20210001669191-21-000107
    EDGAR
Source: ManualCIK 0001836234Share price $2.00

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.